SCHEMBL112765

SCHEMBL112765

CN(C)Cn1ccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7915872 0.77 TBXAS1 (0.56)
Hydrochloric Acid SCHEMBL9171754 0.76 TBXAS1 (0.54)
SCHEMBL413786 0.74 TBXAS1 (0.63)
SCHEMBL1708961 0.73
SCHEMBL9031096 0.73 TBXAS1 (0.47)
SCHEMBL12350 0.72
SCHEMBL682646 0.71
SCHEMBL2697302 0.71 CYP11B1 (0.50)
SCHEMBL15095689 0.71 TBXAS1 (0.70)
SCHEMBL2143890 0.71 TBXAS1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-B1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2008-08-20 EP claimed
CN-108430503-A Compositions and methods for activating 'interferon gene stimulator' dependent signaling 艾杜罗生物科技公司 2018-08-21 CN disclosed
CN-107530415-A For activating the composition and method of the conduction of \" interferon gene stimulant \" dependent signals 艾杜罗生物科技公司 2018-01-02 CN disclosed
EP-2424843-B1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2014-03-26 EP disclosed
EP-2424843-B1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2014-03-26 EP disclosed
US-8598217-B2 Imidazole derivatives and their use as modulators of cyclin dependent kinases ASTEX THERAPEUTICS LTD. (GB) 2013-12-03 US disclosed
CN-102803225-A Imidazole derivatives and their use as modulators of cyclin dependent kinases NOVARTIS AG 2012-11-28 CN disclosed
US-20120101064-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES ASTEX THERAPEUTICS LIMITED (GB) 2012-04-26 US disclosed
US-20120101064-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES ASTEX THERAPEUTICS LIMITED (GB) 2012-04-26 US disclosed
US-20120101064-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES ASTEX THERAPEUTICS LIMITED (GB) 2012-04-26 US disclosed
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO disclosed
US-5234937-A 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1993-08-10 US disclosed
US-5234939-A 3,5-di-tertiary-butyl-4-hydroxyphenyl imidazolyl methanones and related compounds as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1993-08-10 US disclosed
US-5187175-A 2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1993-02-16 US disclosed
EP-0519996-A1 IMIDAZOLES RHONE-POULENC RORER LIMITED (GB) 1992-12-30 EP disclosed
US-5086064-A Inhibitor of 5-lipoxygenase, cycloxygenanse and/or both WARNER-LAMBERT COMPANY (US) 1992-02-04 US disclosed
EP-0455909-A2 5-[1-(Imidazol)methyl]-3,3-disubstituted-2(3H) furanone derivatives MARION MERRELL DOW INC. (US) 1991-11-13 EP disclosed
EP-0449223-A1 3,5-di-tertiary-butyl-4-hydroxyphenyl thiazolyl, oxa-zolyl, and imidazolyl methanones and related compounds as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1991-10-02 EP disclosed
WO-1991013876-A1 IMIDAZOLES RHONE-POULENC RORER LIMITED (GB) 1991-09-19 WO disclosed
US-5039691-A Anticholinergic agents MARION MERRELL DOW INC. (US) 1991-08-13 US disclosed